Âé¶¹´«Ã½

Mergers & Acquisitions

Fulgent Genetics

04/22
|
$170.0 Million
Âé¶¹´«Ã½ served as buy-side advisor for Fulgent Genetics on acquisition of Inform Diagnostics, a portfolio company of Avista Capital Partners
Sub-Type
Buy-Side
Sector

Sub-Sector
Life Sciences Tools & Diagnostics